ArticleFrontiers in oncology2025
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination.
Tao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it